Wells Fargo raised the firm’s price target on National Health Investors to $81 from $69 and keeps an Overweight rating on the shares. The firm offered updated thoughts on Healthcare REITs following Q2 earnings from the group, saying it is maintains a favorable view on Healthcare as a weaker jobs report and lower end consumer point to easing labor costs, which should drive better metrics. The firm is also encouraged the equity market is open for investment capital, the analyst tells investors in the sector note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NHI:
- National Health Investors 2.4M share Spot Secondary priced at $71.25
- Closing Bell Movers: Cisco jumps over 5% after Q4 earnings beat
- National Health Investors 2M share Spot Secondary; price range $70.10-$73.10
- National Health Investors announces offering of 2M shares of common stock
- National Health Investors sees FY24 FFO $4.52-$4.56, consensus $4.40